These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2150022)

  • 1. [A controlled clinical study on the efficacy and tolerability of stepronin in chronic alcoholic liver diseases].
    De Rensis L; Schianchi L; Assunto A; Antenora G; Allocca F; Bossone V
    Clin Ter; 1990 Nov; 135(3):209-13. PubMed ID: 2150022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tolerance of nitrefazole in alcoholics with liver disease. A 4-week placebo-controlled double-blind study].
    Feuerlein W; Heesch D; Schmidt L; Werner HP; Bethge H; Görtelmeyer R
    Fortschr Med; 1984 Apr; 102(14):409-13. PubMed ID: 6144620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of reduced glutathione in alcoholic hepatopathy].
    Bresci G; Piccinocchi M; Banti S
    Minerva Med; 1991 Nov; 82(11):753-5. PubMed ID: 1766577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [High-dose reduced glutathione in the therapy of alcoholic hepatopathy].
    Nardi EA; Devito R; Tiburzi F; Ceccanti M
    Clin Ter; 1991 Jan; 136(1):47-51. PubMed ID: 1826873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy and safety of amtolmetin guacyl in the treatment of acute osteoarthritis].
    Biasi G; Marcolongo R
    Minerva Med; 2001 Oct; 92(5):315-24. PubMed ID: 11675575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of treatment with paromomycin on endotoxemia in patients with alcoholic liver disease--a double-blind, placebo-controlled trial.
    Bode C; Schäfer C; Fukui H; Bode JC
    Alcohol Clin Exp Res; 1997 Nov; 21(8):1367-73. PubMed ID: 9394106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Parenteral S-adenosylmethionine compared to placebos in the treatment of alcoholic liver diseases].
    Diaz Belmont A; Dominguez Henkel R; Uribe Ancira F
    An Med Interna; 1996 Jan; 13(1):9-15. PubMed ID: 8679834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experiments with a new drug in chronic liver diseases, especially alcohol-induced].
    Bel A; Chambon A
    Minerva Dietol Gastroenterol; 1977; 23(3):243-8. PubMed ID: 372846
    [No Abstract]   [Full Text] [Related]  

  • 9. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of domestic glutathione on the alcoholic liver disease].
    Zhang Q; Guo S; Hu D; He N; Zhang J; Zhong S; Chen Y; Zhang D
    Zhonghua Gan Zang Bing Za Zhi; 2000 Aug; 8(4):239-40. PubMed ID: 10951629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metadoxine in alcohol-related pathology].
    Santoni S; Corradini P; Zocchi M; Camarri F
    Clin Ter; 1989 Jul; 130(2):115-22. PubMed ID: 2529084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The therapeutic activity of stepronin in viral hepatitis].
    Bosio G; Bramato C; Salassa B; Andreoni G; Magliocca R
    Minerva Med; 1982 Oct; 73(41):2897-904. PubMed ID: 6752758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A clinical study on the anti-inflammatory activity and gastrointestinal tolerability of amtolmetin guacyl, a new NSAID, compared with diclofenac in aged patients with osteoarticular diseases].
    Tavella A; Ursini G
    Clin Ter; 1997 Nov; 148(11):543-8. PubMed ID: 9494257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An evaluation of the therapeutic activity and tolerance of ST-679 in patients with osteoarthritis at different sites. A controlled double-blind study vs tolmetin].
    Lingetti M; Ciarimboli M; Porfido FA; Imparato L; Sorrentino GP; Garzya G; Saraceni G; Donati G; Nolfe G
    Clin Ter; 1993 Jan; 142(1 Pt 2):29-40. PubMed ID: 8472518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C].
    Pár A; Róth E; Rumi G; Kovács Z; Nemes J; Mózsik G
    Orv Hetil; 2000 Jul; 141(30):1655-9. PubMed ID: 10962902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunomodulator effect of silymarin therapy in chronic alcoholic liver diseases].
    Deák G; Müzes G; Láng I; Niederland V; Nékám K; Gonzalez-Cabello R; Gergely P; Fehér J
    Orv Hetil; 1990 Jun; 131(24):1291-2, 1295-6. PubMed ID: 2195425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
    Kisicki JC; Fiske K; Lyne A
    Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, enzymological and histological changes in chronic diffuse liver diseases following (+)-cyanidanol-3 (Catergen) treatment.
    Halmy L; Dávid K; Nagy I; Stotz G; Kelemen JT
    Acta Physiol Hung; 1984; 64(3-4):461-70. PubMed ID: 6152370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alcoholic hepatopathy. Aspects of drug therapy].
    Del Dotto M; Neri D
    G Clin Med; 1982 Apr; 63(4):228-36. PubMed ID: 7128979
    [No Abstract]   [Full Text] [Related]  

  • 20. [Choleretic and cholagogic effect of sulphuric sulfate water from the springs of Tobiano in cholestasis in alcohol related liver diseases].
    Coiro V; Volpi R; Vescovi PP
    Clin Ter; 1997; 148(1-2):15-22. PubMed ID: 9377833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.